ALPS Medical Breakthroughs ETF Rating $51.20 -0.44 (-0.85%) Closing price 04:10 PM EasternExtended Trading$51.13 -0.07 (-0.14%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatingsShort Interest ALPS Medical Breakthroughs ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SBIO Aggregate RatingModerate Buy 2.79Holdings in SBIO have an aggregate rating of Moderate Buy based on 318 analyst ratings issued in the past year covering 25 companies (57.2% of the portfolio).SBIO Aggregate Price Target$51.20High Prediction$51.20Average Prediction$51.20Low Prediction$51.20Holdings in SBIO have an aggregate price target of $51.20 and a range of $51.20 to $51.20 covering 25 companies (57.2% of the portfolio).SBIO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy22 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ALPS Medical Breakthroughs ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 SBIO Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings3.90%CGONCG Oncology$61.84-0.9%Moderate Buy$87.50 41.5%103.5588 of 5 starsNews Coverage3.56%ORKAOruka Therapeutics$76.68-1.9%Moderate Buy$128.91 68.1%112.5977 of 5 starsAnalyst ForecastInsider Trade3.45%TVTXTravere Therapeutics$53.27+2.8%Moderate Buy$69.50 30.5%123.1448 of 5 stars3.25%DFTXDefinium Therapeutics$34.24-0.4%Moderate Buy$66.00 92.8%213.2739 of 5 stars3.18%DNTHDianthus Therapeutics$74.76-3.6%Moderate Buy$129.83 73.7%152.6695 of 5 starsNews Coverage3.15%MANEVeradermics$112.85-2.9%Moderate Buy$153.00 35.6%91.8405 of 5 stars2.83%EWTXEdgewise Therapeutics$37.02+2.0%Moderate Buy$51.33 38.7%112.6725 of 5 starsAnalyst Forecast2.61%RLAYRelay Therapeutics$17.06-1.7%Moderate Buy$25.92 51.9%142.3948 of 5 stars2.43%XENEXenon Pharmaceuticals$33.90-1.5%Moderate Buy$70.14 106.9%154.3955 of 5 starsAnalyst Downgrade2.35%IDYAIDEAYA Biosciences$33.86-1.2%Moderate Buy$52.36 54.6%163.8432 of 5 starsNews CoverageAnalyst Forecast2.27%AMLXAmylyx Pharmaceuticals$27.03+0.7%Buy$38.86 43.8%103.5453 of 5 stars2.21%ACADACADIA Pharmaceuticals$19.25+3.4%Moderate Buy$31.34 62.8%184.7031 of 5 starsTrending NewsAnalyst Upgrade2.13%TARSTarsus Pharmaceuticals$72.29+2.1%Moderate Buy$100.86 39.5%103.5155 of 5 stars2.11%DNLIDenali Therapeutics$17.87-2.9%Moderate Buy$35.85 100.6%163.6562 of 5 stars1.90%DYNDyne Therapeutics$15.04-1.7%Moderate Buy$33.07 119.9%163.1177 of 5 stars1.86%NAMSNewAmsterdam Pharma$20.01-0.9%Moderate Buy$49.00 144.9%133.248 of 5 stars1.85%ZLABZai Lab$22.50-2.6%Moderate Buy$37.25 65.6%72.7032 of 5 starsNews CoverageGap Up1.75%MBXMBX Biosciences$48.82-0.4%Moderate Buy$87.00 78.2%132.7908 of 5 starsAnalyst Forecast1.63%CLDXCelldex Therapeutics$27.83-1.5%Moderate Buy$61.92 122.5%142.4312 of 5 stars1.57%IRONDisc Medicine$55.74-1.5%Moderate Buy$110.18 97.7%132.6069 of 5 stars1.53%IMNMImmunome$17.20-2.2%Moderate Buy$34.25 99.1%142.8006 of 5 stars1.47%SLSSELLAS Life Sciences Group$11.88-4.3%Hold$10.00 -15.8%30.7136 of 5 stars1.44%VERAVera Therapeutics$26.74-0.2%Moderate Buy$76.86 187.4%153.3134 of 5 starsAnalyst Forecast1.38%VRDNViridian Therapeutics$18.38+0.9%Moderate Buy$38.69 110.5%132.8432 of 5 stars1.35%MLYSMineralys Therapeutics$20.76-1.1%Hold$45.50 119.2%93.5964 of 5 starsAnalyst Upgrade This page (NYSEARCA:SBIO) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...Porter & Company | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyA Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's vis...Weiss Ratings | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredI'm giving you a space stock today. Free.On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...Behind the Markets | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredYou’d Never Guess What Their European Chalet CostEric and Debbie, a couple in their 60s from Burbank, California, retired to a private chalet on a European cou...International Living | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ALPS Medical Breakthroughs ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
